Danaher stock may be turning the corner. What needs to happen to keep it that way
The latest beat-and-raise quarter from Danaher is reviving Wall Street’s hopes for the stock. Can it last? Danaher, a supplier of tools and equipment to drugmakers and hospitals, had been known for decades as an impeccably run company with reliable stock outperformance. However, since its Covid-era record close of nearly $295 per share in September…